Freeline Therapeutics Holdings plc
NASDAQ:FRLN
6.49 (USD) • At close February 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 47.279 | 117.662 | 229.974 | 73.702 | 16.051 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 47.279 | 117.662 | 229.974 | 73.702 | 16.051 |
| Net Receivables
| 1.23 | 2.211 | 16.114 | 11.503 | 8.991 |
| Inventory
| 17.644 | 6.418 | 3.08 | 0.842 | 0.616 |
| Other Current Assets
| 1.474 | 2.001 | 9.008 | 2.999 | 0.431 |
| Total Current Assets
| 67.627 | 128.292 | 258.176 | 89.046 | 26.089 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 15.021 | 9.906 | 8.608 | 7.272 | 5.732 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0.008 | 0.023 | 0 | 0 |
| Goodwill and Intangible Assets
| -1.327 | 0.008 | 0.023 | 0.043 | 0.038 |
| Long Term Investments
| 1.327 | -0.377 | 0 | 0 | 0 |
| Tax Assets
| 0.533 | 0.377 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.46 | 2.919 | 1.805 | 1.029 | 0.275 |
| Total Non-Current Assets
| 19.014 | 12.833 | 10.436 | 8.344 | 6.045 |
| Total Assets
| 86.641 | 141.125 | 268.612 | 97.39 | 32.134 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 10.058 | 5.187 | 8.093 | 5.817 | 1.619 |
| Short Term Debt
| 2.663 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 18.245 | 15.497 | 10.719 | 6.617 | 7.544 |
| Total Current Liabilities
| 30.966 | 20.684 | 18.812 | 12.434 | 9.163 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 3.261 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 3.261 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 34.227 | 20.684 | 18.812 | 12.434 | 9.163 |
| Equity: | |||||
| Preferred Stock
| 0 | 0.137 | 0.155 | 0.001 | 0.001 |
| Common Stock
| 0.137 | 0.137 | 0.155 | 0 | 0 |
| Retained Earnings
| -445.353 | -356.381 | -215.99 | -119.668 | -65.759 |
| Accumulated Other Comprehensive Income/Loss
| -3.151 | 9.472 | 9.342 | -2.999 | -2.845 |
| Other Total Stockholders Equity
| 500.781 | 467.076 | 456.138 | 207.622 | 91.574 |
| Total Shareholders Equity
| 52.414 | 120.441 | 249.8 | 84.956 | 22.971 |
| Total Equity
| 52.414 | 120.441 | 249.8 | 84.956 | 22.971 |
| Total Liabilities & Shareholders Equity
| 86.641 | 141.125 | 268.612 | 97.39 | 32.134 |